Bettina Nowotny

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Placebo Controlled

Pulmonary Arterial Hypertension

Top Venues

Clinical pharmacokinetics

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Michael Boettcher, Bettina Nowotny, Robert Krausche, Corina Becker
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clinical pharmacokinetics 62 (2) (2023)
Bettina Nowotny, Dirk Thomas, Stephan Schwers, Sara Wiegmann, Wolfgang Prange, Ashraf Yassen, Stefanie Boxnick
First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men. Journal of thrombosis and haemostasis : JTH 20 (7) (2022)